Epiendo Pharmaceuticals

This early-stage study tested a drug called EP395 in 49 healthy adults to see if it could reduce inflammation in the lungs. Participants inhaled a substance that causes temporary airway inflammation, and researchers measured whether EP395 lowered that response compared to a place…

This study tested a drug called EP395 in 40 healthy adults to see how it affects temporary lung inflammation caused by an inhaled substance. The goal was to measure changes in blood and lung markers of inflammation and check the drug's safety. Participants were healthy volunteers…

This study looked at how a new drug called EP395 interacts with other common medicines in 37 healthy adults. The goal was to check if EP395 changes how the body processes certain drugs, which is important for future use in people with COPD. Participants took EP395 along with othe…

This early-stage study tested the safety of a new drug called EP395 in 78 healthy adults aged 18 to 65. Participants took single or multiple doses of EP395 in capsule form. The goal was to find a safe dose range for future research. The study focused on side effects, heart activi…